EMA Lapsed: Ribavirin BioPartners (ribavirin) — BioPartners GmbH

View source ↗

Summary

EMA status indicates ribavirin product by BioPartners GmbH has lapsed (withdrawn).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Viral Hepatitis

Drugs mentioned

• Ribavirin (ribavirin)

Snippet

Status: Lapsed. Therapeutic area: Hepatitis C, Chronic. MAH: BioPartners GmbH. Decision date: 21/11/2012